Digital Exclusive: An interview with David Eichenbaum, MD, on his ASRS 2024 presentation
David Eichenbaum, MD, spoke with Modern Retina to provide and overview on his presentation at ASRS 2024 and the current state of geographic atrophy treatment.
Digital Exclusive: A look at the Phase 1 HELIOS trial with Dilsher Dhoot, MD
Dilsher Dhoot, MD, sat down with Modern Retina to provide some insights on the phase 1 HELIOS trial, which he presented on during the 2024 ASRS meeting held in Stockholm, Sweden earlier in 2024.
True-to-life retinal imaging with the new ultra-widefield color RGB modality
Digital exclusive article on red-blue-green ultrawidefield (UWF) imaging
A great leap forward in ophthalmic drug delivery?
“[Gene therapy may] dramatically reduce frequency of treatments.”
The sights of Stockholm
A look back at the 2024 ASRS conference held in Sweden
Higher molar dose in the real world and clinical trials
Pearls from PULSAR, PHOTON, and working practitioners
Spotlight on GA: Promoting early detection and treatment
The unique role of the retina optometrist
Zhang’s journey as the first retina optometrist in Colorado
OCT-based AI analysis brings changes in GA and therapeutic responses into sharp focus
The current state of gene therapy in managing neovascular macular degeneration
Gene therapy offers a promising alternative by potentially providing long-lasting effects from a single treatment.
The future of retina care
Retina is a rapidly advancing field with promising research, technology, and treatment areas. Two stand out as particularly exciting.
Social factors associated with diabetic retinopathy visit adherence
